Rejection resistant CD30.CAR-modified Epstein-Barr virus-specific T cells as an off-the-shelf platform for CD30 + lymphoma von Quach, David H, Ganesh, Haran R, Briones, Yolanda D, Nouraee, Nazila, Ma, Audrey, Hadidi, Yezan F, Sharma, Sandhya, Rooney, Cliona M

Volltext

CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells (CD30.CAR EBVSTs) Provide a Safe and Effective Off-the-Shelf Therapy for Patients with CD30-Positive Lymphoma von Quach, David H., Ramos, Carlos A., Lulla, Premal D., Sharma, Sandhya, Ganesh, Haran R., Nouraee, Nazila, Briones, Yolanda D., Hadidi, Yezan F., Becerra-Dominguez, Luis, Thakkar, Sachin G., Mehta, Birju, Perconti, Silvana, Hsieh, Emily M., Zhang, Huimin, Grilley, Bambi J., Brenner, Malcolm K., Heslop, Helen E., Rouce, Rayne H., Lapteva, Natalia, Rooney, Cliona M.

Volltext

Infectious pseudochromhidrosis in the setting of dupilumab use von Kuo, Molly E., Briones, Naomi F., Helfrich, Yolanda R.

Volltext